ARTICLE
2 October 2023

Bloomberg Intelligence – Arman Oruc's Perspective On The FTC And Pharma And Biotech Industry M&A Impact (Podcast)

GP
Goodwin Procter LLP

Contributor

At Goodwin, we partner with our clients to practice law with integrity, ingenuity, agility, and ambition. Our 1,600 lawyers across the United States, Europe, and Asia excel at complex transactions, high-stakes litigation and world-class advisory services in the technology, life sciences, real estate, private equity, and financial industries. Our unique combination of deep experience serving both the innovators and investors in a rapidly changing, technology-driven economy sets us apart.
Arman Oruc joined the Bloomberg Intelligence podcast to share his views on the FTC, and its impact on M&A for the pharma and biotech industry.
United States Food, Drugs, Healthcare, Life Sciences

Arman Oruc joined the Bloomberg Intelligence podcast to share his views on the FTC, and its impact on M&A for the pharma and biotech industry.

Listen to the podcast here.

The post Bloomberg Intelligence – Arman Oruc's Perspective on the FTC and Pharma and Biotech Industry M&A Impact appeared first on Life Sciences Perspectives.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More